SOPHIA LE: Open Payments
NPI 1447945167 · STONE MOUNTAIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,607 in 74 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $326 · 2025 $1,607
Food & beverage: $1,607
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $275 |
| Sumitomo Pharma America, Inc. | 17 | $212 |
| AstraZeneca Pharmaceuticals LP | 7 | $139 |
| GlaxoSmithKline, LLC. | 2 | $116 |
| Otsuka America Pharmaceutical, Inc. | 5 | $110 |
| PFIZER INC. | 5 | $102 |
| Amgen Inc. | 6 | $93 |
| Lilly USA, LLC | 4 | $83 |
| ABBVIE INC. | 3 | $65 |
| Astellas Pharma US Inc | 3 | $62 |
Products named: Kerendia, GEMTESA, REXULTI, AREXVY, AIRSUPRA, Veozah, EVENITY, QULIPTA.
Industry payments across GA — which companies pay providers there.
